Attempts to cure brain-related disorders have proved less successful than therapies for other major conditions such as heart cancer, even though just as many people suffer from them. About 600 …

Brane Discovery, a newly formed specialty pharmaceutical company focused on the development of novel CNS therapies, announced that it is conducting a Phase I clinical trial for its lead compound …

Amorfix Life Sciences announced the discovery of misfolded superoxide dismutase 1 (SOD1) protein in the brains of people with Alzheimer’s Disease. This breakthrough result suggests that SOD1 is a …

When you think of existentialism, do philosophers like JeanPaul Sartre and Albert Camus come to mind

Markets have been retracing hard the past few days and these are the most important levels we are facing for tomorrow…

Isotechnika Inc. announced that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247. Obtaining the patent in Norway completes the protection over the …

Sosei Group Corporation announced an update on the status of its collaborative project SD118, which is under development for the treatment of neuropathic pain. SD118 has commenced a multiple dose …

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial and viral infections, reports results from a Phase I trial …

CSL Behring gab bekannt, dass in einer klinischen Phase-III-Studie zur Behandlung von Patienten mit hereditärem Angioödem (HAE) mit humanem pasteurisierten C1-Inhibitor-(C1-INH)-Konzentrat der …

Biotech Holdings reports that it has signed an agreement with a private company (the “UAE Distributor”), pursuant to which, for a period of three years with an option to renew, the UAE Distributor …